²é¿´: 1224  |  »Ø¸´: 4

ÂäÑ©º¬Ïã

½ð³æ (ÕýʽдÊÖ)


[½»Á÷] Çó¸ßÊÖ°ïÎÒ·­ÒëÕâÒ»¶Î£¬ÓкܶàרҵÊõÓÉúÃü¿ÆÑ§Õâ¿éµÄ³æ×ÓÓ¦¸ÃºÜÊìϤ

Competitive ELISA for quantification of trastuzumab.
Tissues from BT474 tumor mice that received trastuzumab injections were homogenized in 1 ml of 0.1 M Glycine pH2 with 1% Tween-20 and protease inhibitors followed by a centrifugation (4˚C, 10 min, 14,000 rpm). Six hundred microliters of supernatant was collected, and added with 150 ¦Ìl of 1 M Tris pH8 and 22.5 ¦Ìl of 5 M NaCl to neutralize the pH. Microtiter wells coated with 5 mg/ml rabbit anti-human IgG were incubated with the tissue extracts and 1 ¦Ìg/ml of biotinylated human IgG. After 2 hours of incubation at room temperature, the wells were washed with PBS containing 0.01% Tween 20, added with streptavidin-conjugated horseradish peroxidase, and incubated for 30 minutes at room temperature. The amount of biotinylated human IgG captured on the microtiter wells was quantified with 2,2-azino-bis(3-etylbenzthiazoline-6-sulfonic acid) as a substrate and the absorbance at 405 nm was measured. To obtain standard curves, the tissue extracts were substituted with various concentrations of trastuzumab (ranging from 0.01 to 10 ¦Ìg/ml) in the ELISA.

» ²ÂÄãϲ»¶

» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:

²é¿´È«²¿É¢½ðÌù

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Â¥Ö÷ÄÇô¶àBB£¬¾¹È»ÕâôÁߨġ£¡£¡£¡£
2Â¥2010-12-05 19:27:42
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¼ÓµãbbÈö
3Â¥2010-12-07 16:03:58
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÂäÑ©º¬Ïã

½ð³æ (ÕýʽдÊÖ)


»¹ÈÃÎÒ¼Ó½ð±Ò°¡£¬µ½µ×¼Ó¶àÉٲʻĨ£¬¸É´à°æÖ÷Ū¸ö¹æ¶¨£¬µÍÓÚ¶àÉٵĽð±ÒÎÞ·¨ÇóÌù£¬ÎÒ¼ÈÈ»¿ÉÒÔÇóÌù£¬»áµÄ¾Í»Ø´ð£¬²»ÒªÀÏÔÚÕâÀïÒª½ð±Ò£¬ÎÒÈ«¸øÄãÃǶ¼²»¼ûµÃÄÜÂú×ãÄãÃÇ
4Â¥2010-12-07 19:15:08
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÂäÑ©º¬Ïã

½ð³æ (ÕýʽдÊÖ)


·­ÒëÎÒ×Ô¼º¸ã¶¨ÁË£¬Õâ12¸ö½ð±Ò°®Ë­ÒªË­Òª£¬Ã»ÈËÒªÍ˸øÎÒ
5Â¥2010-12-07 19:16:24
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ÂäÑ©º¬Ïã µÄÖ÷Ìâ¸üÐÂ
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û